76 related articles for article (PubMed ID: 9261198)
1. [New development of cellulose-ferric ammonium citrate solution as a contrast-enhancement agent for magnetic resonance imaging of esophageal diseases].
Ogawa Y; Noda Y; Sawada A; Fujiwara Y; Hamada N; Terashima M; Inomata T; Yoshida S; Morio K
Nihon Igaku Hoshasen Gakkai Zasshi; 1994 Oct; 54(12):1178-80. PubMed ID: 9261198
[TBL] [Abstract][Full Text] [Related]
2. [High concentration ferric ammonium citrate (FAC) solution as a negative bowel contrast agent].
Takahara T; Yoshikawa T; Saeki M; Nosaka S; Shimoyamada K; Nakajima Y; Ishikawa T
Nihon Igaku Hoshasen Gakkai Zasshi; 1995 May; 55(6):425-6. PubMed ID: 7617470
[TBL] [Abstract][Full Text] [Related]
3. [The use of high concentration ferric ammonium citrate (FAC) solution as a negative bowel contrast agent: application in MR cholangiography].
Takahara T; Saeki M; Nosaka S; Shimoyamada K; Suemitsu I; Nakajima Y; Yoshikawa T; Ishikawa T
Nihon Igaku Hoshasen Gakkai Zasshi; 1995 Aug; 55(9):697-9. PubMed ID: 7478957
[TBL] [Abstract][Full Text] [Related]
4. [MR imaging of colonic cancer with retrograde administration of contrast material containing ferric ammonium citrate].
Mizuguchi M; Matsuo Y; Fukahori T; Kudo S
Nihon Igaku Hoshasen Gakkai Zasshi; 1995 Dec; 55(15):1063-5. PubMed ID: 8587850
[TBL] [Abstract][Full Text] [Related]
5. [Clinical efficacy of suppression and visualization of the duodenal fluid in MR cholangiopancreatography using ferric ammonium citrate].
Takahara T; Kurihara Y; Takahashi M; Nakajima Y; Ishikawa T
Nihon Rinsho; 1998 Nov; 56(11):2865-9. PubMed ID: 9847611
[TBL] [Abstract][Full Text] [Related]
6. [Oral ferric ammonium citrate solution in MRCP for diagnosing low-level obstructive jaundice].
Yang P; Zhang YD; Li NF; Li WZ; Zhou GF
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Apr; 32(2):347-50. PubMed ID: 17478951
[TBL] [Abstract][Full Text] [Related]
7. Gastrointestinal contrast agents for MR imaging.
Brown JJ
Magn Reson Imaging Clin N Am; 1996 Feb; 4(1):25-35. PubMed ID: 8673714
[TBL] [Abstract][Full Text] [Related]
8. [MR imaging oral contrast agent mixed with milk for the small intestine].
Hirohashi S; Hirohashi R; Uchida H; Kitano S; Tanaka M; Matsuo N; Ohishi H
Nihon Igaku Hoshasen Gakkai Zasshi; 1994 Jul; 54(8):784-8. PubMed ID: 8072869
[TBL] [Abstract][Full Text] [Related]
9. Ferric ammonium citrate-cellulose paste for opacification of the esophageal lumen on MRI.
Ogawa Y; Noda Y; Morio K; Nishioka A; Inomata T; Yoshida S; Toki T; Ogoshi S
J Comput Assist Tomogr; 1996; 20(3):455-9. PubMed ID: 8626911
[TBL] [Abstract][Full Text] [Related]
10. Nuclear magnetic resonance contrast enhancement study of the gastrointestinal tract of rats and a human volunteer using nontoxic oral iron solutions.
Wesbey GE; Brasch RC; Engelstad BL; Moss AA; Crooks LE; Brito AC
Radiology; 1983 Oct; 149(1):175-80. PubMed ID: 6611926
[TBL] [Abstract][Full Text] [Related]
11. Positive bowel contrast agent for MR imaging of the abdomen: phase II and III clinical trials.
Patten RM; Lo SK; Phillips JJ; Bowman SC; Glazer GM; Wall SD; Bova JG; Harris RD; Wheat RL; Johnson CD
Radiology; 1993 Oct; 189(1):277-83. PubMed ID: 8372205
[TBL] [Abstract][Full Text] [Related]
12. Paramagnetic pharmaceuticals for magnetic resonance imaging.
Wesbey GE; Engelstad BL; Brasch RC
Physiol Chem Phys Med NMR; 1984; 16(2):145-55. PubMed ID: 6095341
[TBL] [Abstract][Full Text] [Related]
13. [Optimization of dosage and exam technique in the use of oral contrast media in magnetic resonance].
Broglia L; Tortora A; Maccioni F; Arpesani R; Marcelli G; Ascarelli A; Rossi P
Radiol Med; 1999 May; 97(5):365-70. PubMed ID: 10432968
[TBL] [Abstract][Full Text] [Related]
14. [Elimination of artifacts in MRCP: technical consideration].
Ohgi K; Satoh K; Tanaka S; Higami T; Furukawa T; Akiyama H; Kimura S; Uehara K; Murata K; Higashi M
Nihon Rinsho; 1998 Nov; 56(11):2854-8. PubMed ID: 9847609
[TBL] [Abstract][Full Text] [Related]
15. [Oral contrast media in the study of the esophagus with magnetic resonance. Proposal of a new preparation].
Squillaci E; Fanucci E; Crecco M; Grandinetti ML; Cecconi L; Squillaci S; Simonetti G; Mattioli M; Vitali L
Radiol Med; 1992 Dec; 84(6):761-6. PubMed ID: 1494679
[TBL] [Abstract][Full Text] [Related]
16. [Nuclear magnetic resonance tomography of the pelvis: rectal administration of a new super-paramagnetic contrast medium].
Kersting-Sommerhoff B; Allgayer B; Western A; Gerhardt P
Rontgenpraxis; 1995 Dec; 48(12):353-6. PubMed ID: 8584960
[No Abstract] [Full Text] [Related]
17. [Magnetic resonance tomography of focal liver and spleen lesions. Experiences using ferrite, a new RES-specific MR contrast medium].
Rummeny E; Weissleder R; Stark DD; Elizondo G; Ferrucci JT
Radiologe; 1988 Aug; 28(8):380-6. PubMed ID: 3174975
[TBL] [Abstract][Full Text] [Related]
18. The clinical impact of magnetic resonance imaging in diagnosing focal hepatic lesions and suspected cancer.
Shah AJ; Parsons B; Pope I; Callaway M; Finch-Jones MD; Thomas MG
Clin Imaging; 2009; 33(3):209-12. PubMed ID: 19411027
[TBL] [Abstract][Full Text] [Related]
19. Contrast agents for functional and cellular MRI of the kidney.
Grenier N; Pedersen M; Hauger O
Eur J Radiol; 2006 Dec; 60(3):341-52. PubMed ID: 16973326
[TBL] [Abstract][Full Text] [Related]
20. [Magnetic resonance imaging of the esophagus with lumen opacification using a specific contrast agent].
Pavone P; Cardone GP; Di Girolamo M; Catalano C; Albertini Petroni G; Cisternino S; Innacoli M; Aytan E; Passariello R
Radiol Med; 1992 Dec; 84(6):756-60. PubMed ID: 1494678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
